Remove Biopharma Remove FDA Remove Food and Drug Administration Remove Pharmacology
article thumbnail

Sunshine Biopharma signs licence deal for Covid-19 treatment

Pharmaceutical Technology

Sunshine Biopharma has signed an exclusive global licence deal with the University of Arizona for PLpro-based Covid-19 treatment. Since February last year, Sunshine Biopharma has been working along with the University of Arizona on this project. Early R&D projects coverage on Pharmaceutical Technology is supported by Mimotopes.